Cargando…
Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A‐4 Derivative, AC7700
The relation between tumor tissue blood flow (tBF) reduction and antitumor effects was investigated. Changes in tBF of normal tissues (liver, kidney cortex, bone marrow and brain cortex) and tumors (Yoshida sarcoma subline, LY80 and Sato lung carcinoma, SLC) due to i.v. administration of AC7700 (1,...
Autores principales: | Hori, Katsuyoshi, Saito, Sachiko, Nihei, Yukio, Suzuki, Manabu, Sato, Yasufumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926172/ https://www.ncbi.nlm.nih.gov/pubmed/10551334 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00851.x |
Ejemplares similares
-
A Novel Combretastatin A‐4 Derivative, AC‐7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors
por: Nihei, Yukio, et al.
Publicado: (1999) -
Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis
por: Hori, K, et al.
Publicado: (2003) -
Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700)
por: Hori, K, et al.
Publicado: (2004) -
A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs
por: Hori, K, et al.
Publicado: (2002) -
Evaluation of Antivascular and Antimitotic Effects of Tubulin Binding Agents in Solid Tumor Therapy
por: Nihei, Yukio, et al.
Publicado: (1999)